BackgroundCheck.run
Search For

Bridget R Duvall, 451117 Cecil Ave, Millersville, MD 21108

Known as:
Bridget D Duvall Bridget R Duval
Related to:
Brian Lee Duvall 66 Wanda J Duvall 88

Bridget Duvall Phones & Addresses

1117 Cecil Ave, Millersville, MD 21108   

7801 Tucker Ave, Nottingham, MD 21236   

Silver Spring, MD   

Vicksburg, MS   

Get Report
Control this profile

Mentions for Bridget R Duvall

Resumes & CV records

Resumes

Bridget Duvall Photo 28

Head Of Operations

Location:
1117 Cecil Ave south, Millersville, MD 21108
Industry:
Pharmaceuticals
Work:
Avidea Technologies
Head of Operations Johns Hopkins School of Medicine
Senior Research Specialist Eisai Research Institute Feb 2008 - Dec 2008
Research Associate Mgi Pharma Oct 2005 - Jan 2008
Research Associate Guilford Pharmaceuticals Jun 2004 - Sep 2005
Research Associate
Education:
University of Maryland 2001 - 2004
Masters, Organic Chemistry Stevenson University 1997 - 2001
Bachelors, Chemistry
Skills:
Research, Organic Chemistry, Drug Discovery, Medicinal Chemistry, Life Sciences, Flash Chromatography, Hplc, Biochemistry, Drug Development, Nmr, Molecular Biology, Biotechnology, Chemistry
Bridget Duvall Photo 29

Bridget Duvall

Bridget Duvall Photo 30

Bridget Duvall

Bridget Duvall Photo 31

Bridget Duvall

Bridget Duvall Photo 32

Bridget Duvall

Publications & IP owners

Us Patents

Certain Compounds, Compositions And Methods

US Patent:
8268800, Sep 18, 2012
Filed:
Oct 16, 2008
Appl. No.:
12/252961
Inventors:
Gregory S. Hamilton - Catonsville MD, US
Takashi Tsukamoto - Ellicott City MD, US
Dana V. Ferraris - Eldersburg MD, US
Bridget Duvall - Nottingham MD, US
Rena Lapidus - Baltimore MD, US
Assignee:
Eisai Inc. - Woodcliff Lake NJ
International Classification:
A01N 43/04
A61K 31/70
C07H 19/00
US Classification:
514 49, 514 50, 536 281, 536 284, 536 2853
Abstract:
The present invention provides certain tetrahydrouridine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of making and using such compounds.

Compositions And Methods For Treating Cancer

US Patent:
8324180, Dec 4, 2012
Filed:
Apr 6, 2010
Appl. No.:
12/755106
Inventors:
Sergei Belyakov - Singapore, SG
Bridget Duvall - Nottingham MD, US
Dana Ferraris - Eldersburg MD, US
Gregory Hamilton - Catonsville MD, US
Mark Vaal - Perry Hall MD, US
Assignee:
Eisai Inc. - Andover MA
International Classification:
A61K 31/7052
A61P 35/00
C07H 19/04
US Classification:
514 43, 536 221
Abstract:
Provided herein are compounds used to inhibit the deamination enzyme responsible for the inactivation of therapeutic compounds, and methods of using them.

Compositions And Methods For Treating Cancer

US Patent:
8329665, Dec 11, 2012
Filed:
Apr 6, 2010
Appl. No.:
12/755116
Inventors:
Sergei Belyakov - Singapore, SG
Bridget Duvall - Nottingham MD, US
Dana Ferraris - Eldersburg MD, US
Gregory Hamilton - Catonsville MD, US
Mark Vaal - Perry Hall MD, US
Assignee:
Eisai Inc. - Andover MA
International Classification:
A61K 31/7072
A61K 31/7052
A61P 35/00
A61P 35/02
US Classification:
514 43, 514 49, 514 50
Abstract:
Provided herein are compounds used to inhibit the deamination enzyme responsible for the inactivation of therapeutic compounds, and methods of using them.

Compositions And Methods For Treating Cancer

US Patent:
8329666, Dec 11, 2012
Filed:
Apr 6, 2010
Appl. No.:
12/755122
Inventors:
Sergei Belyakov - Singapore, SG
Bridget Duvall - Nottingham MD, US
Dana Ferraris - Eldersburg MD, US
Gregory Hamilton - Catonsville MD, US
Mark Vaal - Perry Hall MD, US
Assignee:
Eisai Inc. - Andover MA
International Classification:
A61K 31/706
A61P 35/00
US Classification:
514 43, 514 49, 514 50
Abstract:
Provided herein are methods of treating cancer comprising administering decitabine in combination with compounds that inhibit the deamination enzyme responsible for the inactivation of decitabine.

Compositions And Methods For Treating Cancer

US Patent:
8609631, Dec 17, 2013
Filed:
Oct 31, 2012
Appl. No.:
13/665184
Inventors:
Bridget Duvall - Nottingham MD, US
Dana Ferraris - Eldersburg MD, US
Gregory Hamilton - Catonsville MD, US
Mark Vaal - Perry Hall MD, US
Assignee:
Eisai Inc. - Andover MA
International Classification:
A61K 31/7052
C07H 19/04
US Classification:
514 53, 536 221
Abstract:
Provided herein are compounds used to inhibit the deamination enzyme responsible for the inactivation of therapeutic compounds, and methods of using them.

Certain Compounds, Compositions And Methods

US Patent:
8618075, Dec 31, 2013
Filed:
Jul 24, 2012
Appl. No.:
13/556404
Inventors:
Gregory S. Hamilton - Catonsville MD, US
Takashi Tsukamoto - Ellicott City MD, US
Dana V. Ferraris - Eldersburg MD, US
Bridget Duvall - Nottingham MD, US
Rena Lapidus - Baltimore MD, US
Assignee:
Eisai Inc. - Woodcliff Lake NJ
International Classification:
A01N 43/04
A61K 31/70
C07H 19/00
US Classification:
514 49, 514 50, 536 281, 536 284, 536 2853
Abstract:
The present invention provides certain tetrahydrouridine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of making and using such compounds.

Inhibitors Of D-Amino Acid Oxidase

US Patent:
2015021, Aug 6, 2015
Filed:
Aug 8, 2013
Appl. No.:
14/420236
Inventors:
- BALTIMORE MD, US
Barbara Stauch Slusher - Baltimore MD, US
Dana V. Ferraris - Eldersburg MD, US
Camilo Rojas - Baltimore MD, US
Niyada Hin - Laurel MD, US
Bridget Duvall - Nottingham MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - BALTIMORE MD
International Classification:
C07D 471/04
A61K 31/53
C07D 409/06
C07D 403/06
A61K 31/5377
C07D 401/06
C07D 253/06
A61K 31/198
Abstract:
D-amino acid oxidase (DAAO) inhibitors and methods of their use, either alone or in combination with D-serine or D-alanine, to facilitate allosteric activation of NMDA receptor-mediated neurotransmission and methods of their use as therapeutic agents for treating a subject afflicted with one or more cognitive-disorders, such as schizophrenia, including subjects suffering from negative symptoms and cognitive impairments, post-traumatic stress disorder (PTSD), or pain, are disclosed.

Certain Compounds, Compositions And Methods

US Patent:
2015021, Jul 30, 2015
Filed:
Dec 29, 2014
Appl. No.:
14/584437
Inventors:
- Tokyo, JP
Takashi Tsukamoto - Ellicott City MD, US
Dana V. Ferraris - Eldersberg MD, US
Bridget Duvall - Nottingham MD, US
Rena Lapidus - Baltimore MD, US
International Classification:
C07H 19/06
C07H 1/00
Abstract:
The present invention provides certain tetrahydrouridine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of making and using such compounds.

Possible Relatives

David B Duvall  Dawn Duvall  Deanna Duvall  Dale C Duvall  Deborah H Duvall  Dana M Duvall  Debra J Duvall  Bridget R Johnson  Bridget L Johnston  Bridget W White 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.